This study utilizes scRNA-seq and machine learning technologies to demonstrate that interactions between ECs and FBs mediated by SCARB1 receptors on ECs represent a viable target for managing progressive heart failure with cardiac hypertrophy. Here, SCARB1 is linked to cardiac hypertrophy.